Canadian Adult Congenital Heart Disease Intervention Registry

NCT04288596 · tracked via the Priya Life Science Canada tracker

Sponsor

University Health Network, Toronto

Phase

Observational

Started

2020-04-01

Last updated

2020-02-28

Condition(s) studied

Atrial Septal DefectPatent Foramen OvaleTetralogy of FallotFontanCoarctation of AortaTransposition of Great VesselsPercutaneous Pulmonary Valve Implantation

Investigational drug(s) / intervention(s)

Participants undergoing ACHD intervention

Participants undergoing ACHD intervention: Participants will receive standard of care for their ACHD intervention.

Study summary

The ACHDi Registry study will create a foundational database for adult congenital heart disease interventions. This Pan-Canadian Registry will collect clinical and patient-reported information that will enable the evaluation of care processes and outcomes in five most common ACHDi interventions by enabling prospective and retrospective registry-based studies to answer important clinical practice and policy-relevant questions.

Eligibility

Sex

ALL

Min age

18 Years

Max age

110 Years

Healthy volunteers

Inclusion Criteria: * participants must be 18 years or older referred for intervention for one of five ACHD conditions including diagnostic catheterization for complex ACHD patients (Tetralogy of Fallot, Fontan, and transposition of the great vessels, single ventricle, truncus arteriosus); transcatheter closure of atrial septal defects; transcatheter closure of patent foramen ovale; coarctation of aorta stenting, and percutaneous pulmonary valve implantation. Exclusion Criteria: * participants below the age of 18 * participants residing outside of Canada

Primary outcome measure(s)

the number of subjects enrolled — baseline
This is an observational registry. The primary outcome is the number of subjects enrolled who are undergoing ACHD intervention.

Trial sites (1)

Facility	City	Region	Status
Toronto General Hospital	Toronto	Ontario

More University Health Network, Toronto trials in Canada

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis Recruiting

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy Active, not recruiting

CBF and NCF Changes With Brain Radiation Active, not recruiting

A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T Recruiting

Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial) Recruiting

Other trials for the same condition

NIRS in Congenital Heart Defects - Correlation With Echocardiography Recruiting

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion Active, not recruiting

Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke Recruiting

Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure Recruiting

AMPLATZER PFO Occluder Post Approval Study Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04288596 on ClinicalTrials.gov ↗ ← All trials in Canada